Literature DB >> 25049410

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

Wenhui Hu1, Rafal Kaminski2, Fan Yang2, Yonggang Zhang2, Laura Cosentino2, Fang Li2, Biao Luo3, David Alvarez-Carbonell4, Yoelvis Garcia-Mesa4, Jonathan Karn4, Xianming Mo5, Kamel Khalili1.   

Abstract

AIDS remains incurable due to the permanent integration of HIV-1 into the host genome, imparting risk of viral reactivation even after antiretroviral therapy. New strategies are needed to ablate the viral genome from latently infected cells, because current methods are too inefficient and prone to adverse off-target effects. To eliminate the integrated HIV-1 genome, we used the Cas9/guide RNA (gRNA) system, in single and multiplex configurations. We identified highly specific targets within the HIV-1 LTR U3 region that were efficiently edited by Cas9/gRNA, inactivating viral gene expression and replication in latently infected microglial, promonocytic, and T cells. Cas9/gRNAs caused neither genotoxicity nor off-target editing to the host cells, and completely excised a 9,709-bp fragment of integrated proviral DNA that spanned from its 5' to 3' LTRs. Furthermore, the presence of multiplex gRNAs within Cas9-expressing cells prevented HIV-1 infection. Our results suggest that Cas9/gRNA can be engineered to provide a specific, efficacious prophylactic and therapeutic approach against AIDS.

Entities:  

Keywords:  CRISPR/Cas9; genome editing; latency; reservoir; retrovirus

Mesh:

Substances:

Year:  2014        PMID: 25049410      PMCID: PMC4128125          DOI: 10.1073/pnas.1405186111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.

Authors:  Emily S Wires; David Alvarez; Curtis Dobrowolski; Yun Wang; Marisela Morales; Jonathan Karn; Brandon K Harvey
Journal:  J Neurovirol       Date:  2012-05-22       Impact factor: 2.643

Review 3.  Programmable DNA cleavage in vitro by Cas9.

Authors:  Tautvydas Karvelis; Giedrius Gasiunas; Virginijus Siksnys
Journal:  Biochem Soc Trans       Date:  2013-12       Impact factor: 5.407

4.  An unbiased genome-wide analysis of zinc-finger nuclease specificity.

Authors:  Richard Gabriel; Angelo Lombardo; Anne Arens; Jeffrey C Miller; Pietro Genovese; Christine Kaeppel; Ali Nowrouzi; Cynthia C Bartholomae; Jianbin Wang; Geoffrey Friedman; Michael C Holmes; Philip D Gregory; Hanno Glimm; Manfred Schmidt; Luigi Naldini; Christof von Kalle
Journal:  Nat Biotechnol       Date:  2011-08-07       Impact factor: 54.908

5.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.

Authors:  Seung Woo Cho; Sojung Kim; Jong Min Kim; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

Review 6.  HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.

Authors:  Tae-Wook Chun; Anthony S Fauci
Journal:  AIDS       Date:  2012-06-19       Impact factor: 4.177

7.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

Review 8.  Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?

Authors:  Patrick Younan; John Kowalski; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2013-11-13       Impact factor: 11.454

Review 9.  Newer gene editing technologies toward HIV gene therapy.

Authors:  N Manjunath; Guohua Yi; Ying Dang; Premlata Shankar
Journal:  Viruses       Date:  2013-11-14       Impact factor: 5.048

10.  CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity.

Authors:  Thomas J Cradick; Eli J Fine; Christopher J Antico; Gang Bao
Journal:  Nucleic Acids Res       Date:  2013-08-11       Impact factor: 16.971

View more
  237 in total

1.  Optimization of a multiplex CRISPR/Cas system for use as an antiviral therapeutic.

Authors:  Edward M Kennedy; Anand V R Kornepati; Adam L Mefferd; Joy B Marshall; Kevin Tsai; Hal P Bogerd; Bryan R Cullen
Journal:  Methods       Date:  2015-08-17       Impact factor: 3.608

2.  CRISPR-mediated Activation of Latent HIV-1 Expression.

Authors:  Prajit Limsirichai; Thomas Gaj; David V Schaffer
Journal:  Mol Ther       Date:  2015-11-26       Impact factor: 11.454

Review 3.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

4.  A CRISPR/Cas9 library to map the HIV-1 provirus genetic fitness.

Authors:  K E Yoder
Journal:  Acta Virol       Date:  2019       Impact factor: 1.162

Review 5.  Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.

Authors:  Jay Rappaport; David J Volsky
Journal:  J Neurovirol       Date:  2015-05-02       Impact factor: 2.643

6.  Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity.

Authors:  Janet Karpinski; Ilona Hauber; Jan Chemnitz; Carola Schäfer; Maciej Paszkowski-Rogacz; Deboyoti Chakraborty; Niklas Beschorner; Helga Hofmann-Sieber; Ulrike C Lange; Adam Grundhoff; Karl Hackmann; Evelin Schrock; Josephine Abi-Ghanem; M Teresa Pisabarro; Vineeth Surendranath; Axel Schambach; Christoph Lindner; Jan van Lunzen; Joachim Hauber; Frank Buchholz
Journal:  Nat Biotechnol       Date:  2016-02-22       Impact factor: 54.908

7.  Core Concept: CRISPR gene editing.

Authors:  Amber Dance
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-19       Impact factor: 11.205

8.  Stem cell, CRISPR and HIV.

Authors:  Hsin-Kai Liao; Mo Li; Llanos Martinez Martinez; Juan Carlos Izpisua Belmonte
Journal:  Cell Cycle       Date:  2015-06-03       Impact factor: 4.534

Review 9.  Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.

Authors:  Joshua Kuruvilla; Andrew Octavian Sasmita; Anna Pick Kiong Ling
Journal:  Neurol Sci       Date:  2018-08-03       Impact factor: 3.307

10.  Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study.

Authors:  R Kaminski; R Bella; C Yin; J Otte; P Ferrante; H E Gendelman; H Li; R Booze; J Gordon; W Hu; K Khalili
Journal:  Gene Ther       Date:  2016-05-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.